Patent · US Active

Human anti-mesothelin monoclonal antibodies

US8357783B2 · kind B2 · utility

10Cited by
9References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2009
Grant dateJan 22, 2013
Priority date
Expiry dateJan 21, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/55
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed herein are isolated human monoclonal antibodies that specifically bind human mesothelin with a binding affinity of about 25 nM or less. Nucleic acids encoding these antibodies, expression vectors including these nucleic acid molecules, and isolated host cells that express the nucleic acid molecules are also disclosed. The antibodies can be used to detect human mesothelin in a sample. Methods of diagnosing cancer, or confirming a diagnosis of cancer, are disclosed herein that utilize these antibodies. Methods of treating a subject with cancer are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.